Back to top

Evolus plunges after Q2 miss, guidance cut; Needham downgrades

Evolus plunges after Q2 miss, guidance cut; Needham downgrades

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

AbbVie Inc. (ABBV)

Evolus, Inc. (EOLS)